Medical device company Globus Medical (NYSE ... on improving patient outcomes. Our spine sales force is the most dedicated and talented team in the market. Our innovation engine delivered a ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Annual GAAP net income was $103 million, while non-GAAP adjusted EBITDA stood at $735 million, accounting for 29.2% of total ...

Following the acquisition of Nevro, Globus Medical projects net sales to be in the range of $2.80-$2.90 billion (up from $2.66-$2.69 billion) for 2025. Per a report by Future Business Insights ...

compete successfully (including without limitation success in convincing surgeons to use Globus Medical or Nevro products and the ability to attract and retain sales and other personnel), (vi) rapidly ...

Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...

PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales ...

It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has declined 17% over the past three months. It seems that the market might have ...

In the preceding three months, 5 analysts have released ratings for Globus Medical GMED, presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ...